VENUS REMEDIES
Back to Balance Sheet
|
VENUS REMEDIES Last 5 Year Long Term Provisions History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Long Term Provisions | ₹10 Cr | ₹8.85 Cr | ₹7.95 Cr | ₹7.38 Cr | ₹6.63 Cr |
What is the latest Long Term Provisions ratio of VENUS REMEDIES ?
Year | Long Term Provisions |
---|---|
Mar2024 | ₹10 Cr |
Mar2023 | ₹8.85 Cr |
Mar2022 | ₹7.95 Cr |
Mar2021 | ₹7.38 Cr |
Mar2020 | ₹6.63 Cr |
How is Long Term Provisions of VENUS REMEDIES Trending?
Years | Long Term Provisions | % Change | |
---|---|---|---|
Mar2024 | ₹10 Cr | 15.96 | |
Mar2023 | ₹8.85 Cr | 11.21 | |
Mar2022 | ₹7.95 Cr | 7.84 | |
Mar2021 | ₹7.38 Cr | 11.25 | |
Mar2020 | ₹6.63 Cr | - |
Compare Long Term Provisions of peers of VENUS REMEDIES
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
VENUS REMEDIES | ₹407.9 Cr | 0.9% | -7.7% | -19.9% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹419,764.0 Cr | -0.9% | -4.8% | 50.2% | Stock Analytics | |
DIVIS LABORATORIES | ₹159,306.0 Cr | 3% | 5.9% | 65% | Stock Analytics | |
CIPLA | ₹120,459.0 Cr | 1.5% | 0.1% | 19.9% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹100,168.0 Cr | -0.4% | -8.2% | 7.1% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹95,662.7 Cr | 0.6% | -5.3% | 51% | Stock Analytics |
VENUS REMEDIES Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
VENUS REMEDIES | 0.9% |
-7.7% |
-19.9% |
SENSEX | 3.4% |
0.2% |
21.7% |
You may also like the below Video Courses